Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I.V Papavrine for Labor Induction in Term PROM
NCT07517796Phase 4Recruiting
- Sponsor
- Galilee Medical Center
- Start
- Oct 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of papaverine in premature rupture of membranes (PROM), sponsored by Galilee Medical Center. Started Oct 2025; status: recruiting.
02
Drugs
papaverine
03
Conditions
premature rupture of membranes (PROM)
Beyond the preview
Go deeper on NCT07517796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07517796.